Free Trial

Intelligent Ultrasound Group (IUG) Competitors

Intelligent Ultrasound Group logo
GBX 12.78 -0.07 (-0.54%)
As of 01/21/2025 09:49 AM Eastern

IUG vs. EKF, CREO, NCYT, BELL, POLX, IHC, AVO, MHC, RUA, and SUN

Should you be buying Intelligent Ultrasound Group stock or one of its competitors? The main competitors of Intelligent Ultrasound Group include EKF Diagnostics (EKF), Creo Medical Group (CREO), Novacyt (NCYT), Belluscura (BELL), Polarean Imaging (POLX), Inspiration Healthcare Group (IHC), Advanced Oncotherapy (AVO), MyHealthChecked (MHC), RUA Life Sciences (RUA), and Surgical Innovations Group (SUN). These companies are all part of the "medical devices" industry.

Intelligent Ultrasound Group vs.

Intelligent Ultrasound Group (LON:IUG) and EKF Diagnostics (LON:EKF) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, risk, dividends, valuation, media sentiment, analyst recommendations, earnings, institutional ownership and community ranking.

In the previous week, Intelligent Ultrasound Group and Intelligent Ultrasound Group both had 1 articles in the media. EKF Diagnostics' average media sentiment score of 0.67 beat Intelligent Ultrasound Group's score of 0.00 indicating that EKF Diagnostics is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Intelligent Ultrasound Group
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
EKF Diagnostics
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

EKF Diagnostics received 327 more outperform votes than Intelligent Ultrasound Group when rated by MarketBeat users.

CompanyUnderperformOutperform
Intelligent Ultrasound GroupN/AN/A
EKF DiagnosticsOutperform Votes
327
76.76%
Underperform Votes
99
23.24%

EKF Diagnostics has a net margin of 9.37% compared to Intelligent Ultrasound Group's net margin of -33.78%. EKF Diagnostics' return on equity of 7.58% beat Intelligent Ultrasound Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Intelligent Ultrasound Group-33.78% -36.19% -13.51%
EKF Diagnostics 9.37%7.58%5.27%

EKF Diagnostics has higher revenue and earnings than Intelligent Ultrasound Group. Intelligent Ultrasound Group is trading at a lower price-to-earnings ratio than EKF Diagnostics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Intelligent Ultrasound Group£9.88M4.23-£3.43M-£0.01-1,278.00
EKF Diagnostics£50.95M2.29£4.78M£0.012,570.00

Intelligent Ultrasound Group has a beta of 0.38, suggesting that its stock price is 62% less volatile than the S&P 500. Comparatively, EKF Diagnostics has a beta of 0.57, suggesting that its stock price is 43% less volatile than the S&P 500.

75.5% of Intelligent Ultrasound Group shares are held by institutional investors. Comparatively, 70.3% of EKF Diagnostics shares are held by institutional investors. 12.8% of Intelligent Ultrasound Group shares are held by company insiders. Comparatively, 5.2% of EKF Diagnostics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

EKF Diagnostics beats Intelligent Ultrasound Group on 10 of the 13 factors compared between the two stocks.

Get Intelligent Ultrasound Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for IUG and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IUG vs. The Competition

MetricIntelligent Ultrasound GroupMedical Devices IndustryMedical SectorLON Exchange
Market Cap£41.80M£2.34B£5.39B£2.04B
Dividend YieldN/A2.37%5.37%5.16%
P/E Ratio-1,278.00218.2088.911,926.65
Price / Sales4.23206.191,280.48384,006.48
Price / Cash7.1515.3836.6029.21
Price / Book6.394.404.963.08
Net Income-£3.43M£77.46M£117.89M£183.60M
7 Day Performance0.87%2.48%1.68%1.24%
1 Month Performance1.59%11.31%3.63%3.43%
1 Year Performance46.06%24.02%26.16%43.35%

Intelligent Ultrasound Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IUG
Intelligent Ultrasound Group
N/AGBX 12.78
-0.5%
N/A+40.1%£41.80M£9.88M-1,278.0065
EKF
EKF Diagnostics
N/AGBX 26.35
+2.5%
N/A-19.9%£119.56M£50.95M2,635.00356Gap Up
High Trading Volume
CREO
Creo Medical Group
N/AGBX 19
+2.7%
N/A-55.4%£68.74M£30.30M-316.67279News Coverage
NCYT
Novacyt
N/AGBX 58.16
+3.9%
N/A-4.4%£41.08M£18.56M-111.84120News Coverage
BELL
Belluscura
N/AGBX 8.95
-0.6%
N/A-52.3%£15.06M£1.80M-89.4524High Trading Volume
POLX
Polarean Imaging
N/AGBX 1.21
-1.3%
N/A-85.2%£14.63M£1.87M-60.4528
IHC
Inspiration Healthcare Group
N/AGBX 13
+1.2%
N/A-71.8%£11.66M£34.30M-92.86224High Trading Volume
AVO
Advanced Oncotherapy
N/AN/AN/AN/A£9.50MN/A-25.003,900Gap Down
MHC
MyHealthChecked
N/AGBX 15.49
-3.2%
N/A+61.5%£8.06M£9.39M-774.5016Gap Up
RUA
RUA Life Sciences
N/AGBX 11.66
-2.8%
N/A-1.1%£7.24M£2.19M-291.5048Gap Down
SUN
Surgical Innovations Group
N/AGBX 0.58
+5.5%
N/A-16.2%£5.41M£12.54M-21.1180Gap Up

Related Companies and Tools


This page (LON:IUG) was last updated on 1/22/2025 by MarketBeat.com Staff
From Our Partners